Single cell Analysis Market

Single cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) & Region - Global Forecast to 2028

Report Code: BT 4224 Jun, 2023, by marketsandmarkets.com

The global single cell analysis market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $7.1 billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as rising prevalence of cancer, increasing R&D in the pharmaceutical & biotechnology industries for complex diseases, and the technological advancements, are driving the market growth.

Attractive Opportunities in the Single Cell Analysis Market

Single Cell Analysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Single Cell Analysis Market

Single Cell Analysis Market Dynamics

DRIVER: Growing prevalence of cancer

Single-cell analysis plays a crucial role in identifying biomarkers associated with cancer. According to GLOBOCAN, the number of cancer cases will rise to approximately 30 million by 2040. Cancer is a highly heterogeneous disease, characterized by diverse cell populations within a tumor. Single-cell analysis enables researchers to dissect this heterogeneity and study individual cancer cells at the molecular level. By analyzing gene expression, genetic mutations, and other cellular characteristics at the single-cell level, researchers gain a comprehensive understanding of tumor heterogeneity.

RESTRAINT: High cost of single-cell analysis products

The high costs of single-cell analysis products present significant obstacles for emerging markets and research institutions in developing countries. These regions often face financial limitations, currency fluctuations, and limited access to resources, making it even more challenging to invest in expensive single-cell analysis technologies. The cost implications of single-cell analysis products can hamper collaborations among research institutions. Sharing data and replicating experiments become complex when the required instruments and reagents are costly and not universally accessible.

OPPORTUNITY: High growth potential of single-cell sequencing

Single-cell sequencing offers exceptional resolution, allowing researchers to capture the cellular heterogeneity present within complex biological systems. Unlike traditional bulk sequencing methods that provide averaged results, single-cell sequencing enables the identification and analysis of individual cells. This improved resolution empowers researchers to uncover rare cell types, identify subpopulations, and explore dynamic cellular states, leading to a deeper understanding of biological processes and disease mechanisms.

CHALLENGE: Standardization of Protocols and Data Integration

Single-cell analysis encompasses a wide range of techniques and protocols, from cell isolation and sample preparation to data analysis. There is a lack of standardized protocols across different laboratories and platforms, leading to variability and inconsistency in experimental procedures. This makes it challenging to compare and integrate data generated from different studies, hindering reproducibility and data sharing. Single-cell analysis generates large and complex datasets, including gene expression profiles, genomic variations, and phenotypic data at the individual cell level. Integrating and comparing these datasets across studies can be challenging due to differences in experimental conditions, technologies, and analysis pipelines. Harmonizing data from different sources and platforms is crucial for meaningful cross-study comparisons and to unlock the full potential of single-cell analysis.

The consumables segment dominated the single cell analysis industry in 2022.

Based on product, the single cell analysis market is broadly segmented into consumables and instruments. In 2022, consumables accounted for the dominant share of the single cell analysis industry. This segment's large share can be attributed to factors such as the preference of researchers for the single-cell analysis techniques and associated consumables; and repetitive purchase of consumables compared to instruments. Furthermore, the increasing adoption of high-throughput technologies is likely to upsurge the growth of the segment.

The research applications segment of single cell analysis industry is expected to grow at the highest CAGR during the forecast period.

Based on application, the single cell analysis market is segmented into research applications, and medical applications. The research applications segment is expected to register the highest CAGR during the forecast period. Advancement in single-cell technologies is one of the factors driving the market growth.

North America dominated single cell analysis industry in 2022.

Geographically, the single cell analysis market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for single-cell analysis in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including strong research infrastructure, high investment in research and development, and presence of key players, account for the major share of the American market.

Single Cell Analysis Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the single cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), 10x Genomics (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Standard BioTools (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), DiaSorin S.p.A. (Italy), Takara Bio, Inc. (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), RareCyte, Inc. (US), and On-chip Biotechnologies Co., Ltd. (Japan).

Scope of the Single Cell Analysis Industry

Report Metric 

Details 

Market Revenue in 2023

$3.5 billion

Projected Revenue by 2028

$7.1 billion

Revenue Rate

Poised to Grow at a CAGR of 15.1%

Market Driver

Growing prevalence of cancer

Market Opportunity

High growth potential of single-cell sequencing

This report categorizes the single cell analysis market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Consumables
  • Beads
  • Microplates
  • Reagents
  • Assay Kits
  • Immunoassays
  • Cell-based Assays
  • Other Consumables
  • Instruments
  • Flow Cytometers
  • NGS Systems
  • PCR Instruments
  • Spectrophotometers
  • Microscopes
  • Cell Counters
  • HCS Systems
  • Microarrays
  • Other Instruments

By Cell Type

  • Human Cells
  • Animal Cells
  • Microbial Cells

By Technique

  • Flow Cytometry
  • Next-generation Sequencing
  • Polymerase Chain Reaction
  • Microscopy
  • Mass Spectrometry
  • Other Techniques

By Application

  • Research Applications
  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Other Research Applications
  • Medical Applications
  • Noninvasive Prenatal Diagnosis
  • in Vitro Fertilization
  • Circulating Tumor Cell Detection

By End users

  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Cell Banks & IVF Centers

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • MEA

Recent Developments of Stem Cell Analysis Industry

  • In May 2023, Becton, Dikinson and Company launched BD FACSDiscover S8 Cell Sorter, new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
  • In June 2022, Merck KGaA collaborated with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.
  • In August 2021, Danaher Corporation acquired the Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 40)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 SINGLE CELL ANALYSIS INDUSTRY SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY 
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 46)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    FIGURE 3 SINGLE CELL ANALYSIS MARKET: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 6 INSIGHTS ON MARKET FROM PRIMARY EXPERTS
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 7 MARKET GROWTH RATE PROJECTION, 2023–2028
          FIGURE 8 SINGLE CELL ANALYSIS INDUSTRY: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
 
3 EXECUTIVE SUMMARY (Page No. - 56)
    FIGURE 10 SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 SINGLE CELL ANALYSIS INDUSTRY, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF SINGLE CELL ANALYSIS INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 61)
    4.1 SINGLE CELL ANALYSIS MARKET OVERVIEW 
          FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE MARKET
    4.2 NORTH AMERICA: SINGLE CELL ANALYSIS INDUSTRY SHARE, BY PRODUCT & COUNTRY (2022) 
          FIGURE 17 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 
          FIGURE 18 CONSUMABLES WILL CONTINUE TO DOMINATE MARKET IN 2028
    4.4 MARKET SHARE, BY END USER, 2023 VS. 2028 
          FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023
    4.5 MARKET: REGIONAL GROWTH OPPORTUNITIES 
          FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MARKET FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 64)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 SINGLE CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 SINGLE CELL ANALYSIS INDUSTRY: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in single-cell analysis products
                                TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES
                    5.2.1.2 Rising prevalence of cancer
                                TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035
                    5.2.1.3 Increasing R&D in pharmaceutical & biotechnology industries for complex diseases
                                FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014–2028
                    5.2.1.4 Growth in stem cell research
                    5.2.1.5 Growing focus on personalized medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of single-cell analysis products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth potential of single-cell sequencing
                    5.2.3.2 Integration of microfluidics in single-cell analysis
                    5.2.3.3 Emerging Asian markets
           5.2.4 CHALLENGES
                    5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 23 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS
    5.4 INDICATIVE PRICING ANALYSIS 
          TABLE 5 AVERAGE PRICE RANGE OF SINGLE-CELL ANALYSIS PRODUCTS (2022)
          TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2022)
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 24 MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 25 SUPPLY CHAIN ANALYSIS OF MARKET
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: MARKET
          TABLE 7 MARKET ECOSYSTEM
    5.8 REGULATORY ANALYSIS 
          TABLE 8 REGULATORY SCENARIO
    5.9 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 9 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 THREAT OF NEW ENTRANTS
           5.9.2 THREAT OF SUBSTITUTES
           5.9.3 BARGAINING POWER OF BUYERS
           5.9.4 BARGAINING POWER OF SUPPLIERS
           5.9.5 INTENSITY OF COMPETITIVE RIVALRY
    5.10 KEY CONFERENCES & EVENTS IN 2023–2024 
           TABLE 10 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.11 TECHNOLOGY ANALYSIS 
           TABLE 11 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES
    5.12 KEY STAKEHOLDERS & BUYING CRITERIA 
           FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS
           FIGURE 28 KEY BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS
    5.13 PATENT ANALYSIS 
           FIGURE 29 PATENTS GRANTED IN MARKET OVER LAST 10 YEARS
           TABLE 12 INDICATIVE LIST OF PATENTS IN MARKET
 
6 SINGLE CELL ANALYSIS MARKET, BY PRODUCT (Page No. - 86)
    6.1 INTRODUCTION 
          TABLE 13 SINGLE CELL ANALYSIS INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 CONSUMABLES 
          TABLE 14 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 15 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 16 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 BEADS
                    6.2.1.1 Wide application of beads in isolation of RNA and DNA to drive market
                                TABLE 17 SINGLE-CELL ANALYSIS BEADS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 18 SINGLE-CELL ANALYSIS BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 MICROPLATES
                    6.2.2.1 Increasing demand for genomic technologies to boost market
                                TABLE 19 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 20 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 REAGENTS
                    6.2.3.1 Advancements in single-cell genomics to increase adoption of reagents
                                TABLE 21 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 22 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 ASSAY KITS
                    TABLE 23 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 24 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 25 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.4.1 Immunoassays
                               6.2.4.1.1 Innovations in immunoassays to drive growth
                                              TABLE 26 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 27 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.4.2 Cell-based assays
                               6.2.4.2.1 Rising R&D activities in pharma and biopharma companies to drive demand
                                              TABLE 28 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 29 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.5 OTHER CONSUMABLES
                    TABLE 30 ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 31 ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 INSTRUMENTS 
          TABLE 32 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 33 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 34 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 FLOW CYTOMETERS
                    6.3.1.1 Technological advancements in flow cytometry to drive market
                                TABLE 35 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 36 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 NGS SYSTEMS
                    6.3.2.1 Advancements in NGS systems to support market growth
                                TABLE 37 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 38 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 PCR INSTRUMENTS
                    6.3.3.1 Use of PCR to amplify DNA and mRNA from single cells to study gene expression to boost market growth
                                TABLE 39 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 40 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 SPECTROPHOTOMETERS
                    6.3.4.1 Significant technological advancements to favor market growth
                                TABLE 41 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 42 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.5 CELL COUNTERS
                    6.3.5.1 Reliable and quick results to support adoption
                                TABLE 43 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 44 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.6 MICROSCOPES
                    6.3.6.1 Wide applications in cell-based research to drive adoption
                                TABLE 45 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 46 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.7 HCS SYSTEMS
                    6.3.7.1 Increasing need for multi-parametric cell analysis to drive adoption
                                TABLE 47 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 48 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.8 MICROARRAYS
                    6.3.8.1 Increasing demand in molecular biology to support market growth
                                TABLE 49 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 50 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.9 OTHER INSTRUMENTS
                    TABLE 51 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 SINGLE CELL ANALYSIS MARKET, BY CELL TYPE (Page No. - 116)
    7.1 INTRODUCTION 
          TABLE 53 SINGLE CELL ANALYSIS INDUSTRY, BY CELL TYPE, 2021–2028 (USD MILLION)
    7.2 HUMAN CELLS 
           7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET
                    TABLE 54 MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 55 MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 ANIMAL CELLS 
           7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET
                    TABLE 56 MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 57 MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 MICROBIAL CELLS 
           7.4.1 RISING GOVERNMENT SUPPORT TO DETECT AND COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET
                    TABLE 58 MARKET FOR MICROBIAL CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 59 MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 SINGLE CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 123)
    8.1 INTRODUCTION 
          TABLE 60 SINGLE CELL ANALYSIS INDUSTRY, BY TECHNIQUE, 2021–2028 (USD MILLION)
    8.2 FLOW CYTOMETRY 
           8.2.1 WIDE USAGE TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET
                    TABLE 61 MARKET FOR FLOW CYTOMETRY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 62 MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 NEXT-GENERATION SEQUENCING 
           8.3.1 ADVANTAGES SUCH AS EFFECTIVE SCREENING AND MANAGEMENT OF HIGH-VOLUME DATA TO BOOST ADOPTION
                    TABLE 63 MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 64 MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 POLYMERASE CHAIN REACTION 
           8.4.1 ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH
                    TABLE 65 MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 66 MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 MICROSCOPY 
           8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET
                    TABLE 67 MARKET FOR MICROSCOPY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 68 MARKET FOR MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 MASS SPECTROMETRY 
           8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH
                    TABLE 69 MARKET FOR MASS SPECTROMETRY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 70 MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
    8.7 OTHER TECHNIQUES 
          TABLE 71 MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 72 MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 SINGLE CELL ANALYSIS MARKET, BY APPLICATION (Page No. - 134)
    9.1 INTRODUCTION 
          TABLE 73 SINGLE CELL ANALYSIS INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 RESEARCH APPLICATIONS 
          TABLE 74 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 75 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 76 MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.1 CANCER RESEARCH
                    9.2.1.1 Growing prevalence of cancer to support market growth
                                TABLE 77 MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 78 MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.2 IMMUNOLOGY RESEARCH
                    9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market
                                TABLE 79 MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 80 MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.3 NEUROLOGY RESEARCH
                    9.2.3.1 Increasing incidence of neurological disorders to propel market
                                TABLE 81 MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 82 MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.4 STEM CELL RESEARCH
                    9.2.4.1 Rising investments in stem cell research to drive market
                                TABLE 83 MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 84 MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.5 OTHER RESEARCH APPLICATIONS
                    TABLE 85 MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 86 MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 MEDICAL APPLICATIONS 
          TABLE 87 MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 88 MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 89 MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.1 NONINVASIVE PRENATAL DIAGNOSIS
                    9.3.1.1 Rising prevalence of genetic diseases to drive market
                                TABLE 90 MARKET FOR NONINVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 91 MARKET FOR NON INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.2 IN VITRO FERTILIZATION
                    9.3.2.1 Increasing demand for IVF procedures to support market growth
                                TABLE 92 MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 93 MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.3 CIRCULATING TUMOR CELL DETECTION
                    9.3.3.1 Rising prevalence of cancer to drive market
                                TABLE 94 MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 95 MARKET FOR CIRCULATING TUMOUR CELL DETECTION, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 SINGLE CELL ANALYSIS MARKET, BY END USER (Page No. - 152)
     10.1 INTRODUCTION 
             TABLE 96 SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.2 ACADEMIC & RESEARCH LABORATORIES 
             10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET
                        TABLE 97 MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 98 MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 
             10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH
                        TABLE 99 MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 100 MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 HOSPITALS & DIAGNOSTIC LABORATORIES 
             10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE ADOPTION
                        TABLE 101 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 102 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 CELL BANKS & IVF CENTERS 
             10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH
                        TABLE 103 MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 104 MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 SINGLE CELL ANALYSIS MARKET, BY REGION (Page No. - 161)
     11.1 INTRODUCTION 
             TABLE 105 SINGLE CELL ANALYSIS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: SINGLE CELL ANALYSIS MARKET SNAPSHOT
             TABLE 106 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 107 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 108 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 109 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 110 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 111 NORTH AMERICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 112 NORTH AMERICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 113 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 114 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 115 NORTH AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 116 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Increasing R&D investments and funding to drive market
                                      FIGURE 31 NIH FUNDING FOR STEM CELL RESEARCH (2011–2021)
                                      TABLE 117 US: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 118 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 119 US: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 US: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 122 US: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 123 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 124 US: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 US: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 126 US: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 High prevalence of hemophilia to drive market
                                      TABLE 127 CANADA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 128 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 129 CANADA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 130 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 131 CANADA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 132 CANADA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 133 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 134 CANADA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 135 CANADA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 136 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 NORTH AMERICA: RECESSION IMPACT
     11.3 EUROPE 
             TABLE 137 EUROPE: SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 138 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 139 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 140 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 141 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 142 EUROPE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 143 EUROPE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 144 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 145 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 146 EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 147 EUROPE: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Government support for research funding to propel market
                                      TABLE 148 GERMANY: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 149 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 150 GERMANY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 151 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 152 GERMANY: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 153 GERMANY: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 154 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 155 GERMANY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 GERMANY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 157 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Favorable research conditions to support market growth
                                      TABLE 158 UK: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 159 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 160 UK: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 161 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 162 UK: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 UK: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 164 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 165 UK: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 166 UK: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 167 UK: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 High burden of cancer to propel market
                                      TABLE 168 FRANCE: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 169 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 170 FRANCE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 171 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 172 FRANCE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 173 FRANCE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 174 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 175 FRANCE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 176 FRANCE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 177 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Increasing cell biology seminars and conferences to drive market
                                      TABLE 178 ITALY: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 179 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 180 ITALY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 181 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 182 ITALY: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 183 ITALY: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 184 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 185 ITALY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 186 ITALY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 187 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to drive market
                                      TABLE 188 SPAIN: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 189 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 190 SPAIN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 191 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 192 SPAIN: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 193 SPAIN: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 194 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 195 SPAIN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 196 SPAIN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 197 SPAIN: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.3.6 REST OF EUROPE
                        TABLE 198 REST OF EUROPE: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 199 REST OF EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 200 REST OF EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 201 REST OF EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 202 REST OF EUROPE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 203 REST OF EUROPE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 204 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 205 REST OF EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 206 REST OF EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 207 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.7 EUROPE: RECESSION IMPACT
     11.4 ASIA PACIFIC 
             FIGURE 32 ASIA PACIFIC: SINGLE CELL ANALYSIS MARKET SNAPSHOT
             TABLE 208 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 209 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 210 ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 212 ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 213 ASIA PACIFIC: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 214 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 215 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 216 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 217 ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 218 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 Government initiatives to promote stem cell research to propel market
                                      TABLE 219 CHINA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 220 CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 221 CHINA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 222 CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 223 CHINA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 224 CHINA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 225 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 226 CHINA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 227 CHINA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 228 CHINA: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Rising geriatric population and growing focus on personalized medicine to drive market
                                      TABLE 229 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
                                      TABLE 230 JAPAN: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 231 JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 JAPAN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 233 JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 234 JAPAN: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 235 JAPAN: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 236 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 237 JAPAN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 238 JAPAN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 239 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Expansion of pharmaceutical and biotechnology industries to support market growth
                                      TABLE 240 INDIA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 241 INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 242 INDIA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 243 INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 244 INDIA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 245 INDIA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 246 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 247 INDIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 INDIA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 249 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 REST OF ASIA PACIFIC
                        TABLE 250 REST OF ASIA PACIFIC: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 251 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 252 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 253 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 254 REST OF ASIA PACIFIC: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 255 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 256 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 257 REST OF ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 258 REST OF ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 259 REST OF ASIA PACIFIC: SINGLE CELL ANALYSIS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 ASIA PACIFIC: RECESSION IMPACT
     11.5 LATIN AMERICA 
             11.5.1 EXPANSION OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET
             11.5.2 LATIN AMERICA: RECESSION IMPACT
                        TABLE 260 LATIN AMERICA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 261 LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 263 LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 264 LATIN AMERICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 265 LATIN AMERICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 266 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 267 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 268 LATIN AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 269 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES TO DRIVE MARKET
             11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 270 MIDDLE EAST & AFRICA: SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 271 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 272 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 273 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 274 MIDDLE EAST & AFRICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 275 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 276 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 277 MIDDLE EAST & AFRICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 278 MIDDLE EAST & AFRICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 279 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 254)
     12.1 INTRODUCTION 
     12.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS 
             FIGURE 33 SINGLE CELL ANALYSIS MARKET: STRATEGIES ADOPTED
     12.3 REVENUE ANALYSIS 
             FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES, 2020–2022
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 35 SINGLE CELL ANALYSIS INDUSTRY SHARE, BY KEY PLAYER (2022)
             TABLE 280 SINGLE CELL ANALYSIS INDUSTRY: DEGREE OF COMPETITION
     12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 36 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS, 2022
     12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 37 MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
     12.7 COMPETITIVE BENCHMARKING 
             12.7.1 COMPANY FOOTPRINT ANALYSIS (25 COMPANIES)
                        TABLE 281 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             12.7.2 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
                        TABLE 282 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
             12.7.3 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES)
                        TABLE 283 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN MARKET
     12.8 COMPETITIVE SCENARIO AND TRENDS 
             12.8.1 PRODUCT LAUNCHES
                        TABLE 284 MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023
             12.8.2 DEALS
                        TABLE 285 MARKET: DEALS, JANUARY 2020–MAY 2023
             12.8.3 EXPANSIONS
                        TABLE 286 SINGLE CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2020–MAY 2023
 
13 COMPANY PROFILES (Page No. - 266)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
     13.1 KEY COMPANIES 
             13.1.1 BECTON, DICKINSON AND COMPANY
                        TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
                        FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             13.1.2 DANAHER CORPORATION
                        TABLE 288 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.3 MERCK KGAA
                        TABLE 289 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
             13.1.4 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 290 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
             13.1.5 QIAGEN N.V.
                        TABLE 291 QIAGEN N.V.: COMPANY OVERVIEW
                        FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
             13.1.6 10X GENOMICS
                        TABLE 292 10X GENOMICS: COMPANY OVERVIEW
                        FIGURE 43 10X GENOMICS: COMPANY SNAPSHOT (2022)
             13.1.7 ILLUMINA, INC.
                        TABLE 293 ILLUMINA, INC.: COMPANY OVERVIEW
                        FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
             13.1.8 BIO-RAD LABORATORIES
                        TABLE 294 BIO-RAD LABORATORIES: COMPANY OVERVIEW
                        FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2022)
             13.1.9 PROMEGA CORPORATION
                        TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW
             13.1.10 STANDARD BIOTOOLS
                        TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
                        FIGURE 46 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
             13.1.11 AGILENT TECHNOLOGIES, INC.
                        TABLE 297 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.12 CORNING INCORPORATED
                        TABLE 298 CORNING INCORPORATED: COMPANY OVERVIEW
                        FIGURE 48 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
             13.1.13 TAKARA BIO INC.
                        TABLE 299 TAKARA BIO INC.: COMPANY OVERVIEW
                        FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
             13.1.14 BIOMÉRIEUX SA
                        TABLE 300 BIOMÉRIEUX SA.: COMPANY OVERVIEW
                        FIGURE 50 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
             13.1.15 TECAN GROUP LTD.
                        TABLE 301 TECAN GROUP LTD.: COMPANY OVERVIEW
                        FIGURE 51 TECAN GROUP LTD.: COMPANY SNAPSHOT (2022)
             13.1.16 SARTORIUS AG
                        TABLE 302 SARTORIUS AG: COMPANY OVERVIEW
                        FIGURE 52 SARTORIUS AG: COMPANY SNAPSHOT (2022)
             13.1.17 DIASORIN S.P.A.
                        TABLE 303 DIASORIN S.P.A.: COMPANY OVERVIEW
                        FIGURE 53 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022)
     13.2 OTHER PLAYERS 
             13.2.1 OXFORD NANOPORE TECHNOLOGIES PLC
             13.2.2 CYTEK BIOSCIENCES
             13.2.3 FLUXION BIOSCIENCES INC.
             13.2.4 MENARINI SILICON BIOSYSTEMS
             13.2.5 APOGEE FLOW SYSTEMS LTD.
             13.2.6 NANOCELLECT BIOMEDICAL
             13.2.7 ON-CHIP BIOTECHNOLOGIES CO., LTD.
             13.2.8 RARECYTE, INC.
 
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 337)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

Research for this study involved estimating the current size and forecast of the single cell analysis market through secondary and primary research. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent markets. The next step was to validate these findings & assumptions with industry experts across the value chain through primary research. The market estimates arrived by top-down and other approaches were triangulated to estimate the market size of segments and subsegments. Market growth forecasts were derived by developing assumptions based on revenue growth & key developments from major market players, industry drivers and inputs from demand and supply side experts.

Secondary Research

The secondary sources referred to for this research study include publications from government and private sources such as World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), Organisation for Economic Co-operation and Development (OECD), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global single cell analysis market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Single Cell Analysis Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down approach was used to estimate and validate the total size of the single cell analysis market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single-cell analysis products business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-cell analysis refers to the process of examining and characterizing individual cells to gain insights into their unique properties and functions. It involves the isolation of individual cells from a population, followed by the analysis of various cellular features, such as gene expression, protein levels, epigenetic modifications, metabolites, or cell morphology.

Key Stakeholders

  • Single-cell analysis product manufacturers
  • Cell biology associations
  • Research & consulting firms
  • Distributors of single-cell analysis products
  • Contract manufacturers of global single-cell analysis products
  • Biotechnology, biopharmaceutical, and pharmaceutical companies
  • Healthcare institutes (hospitals, medical schools, diagnostic centers, cell banks, and outpatient clinics)
  • Research institutes and clinical research organizations (CROs)
  • Venture capitalists
  • Insurance providers
  • Government bodies

Report Objectives

  • To define, describe, and forecast the global single cell analysis market based on the product, cell type, technique, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell isolation market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, agreements, collaborations, and R&D activities in the single cell analysis market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe single cell analysis market into respective countries
  • Further breakdown of the Rest of Asia Pacific single cell analysis market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Company Information

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4224
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single cell Analysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback